ReNeuron Group is partnering with the University of Cardiff under a new grant-funded collaboration that will utilise its exosome-based drug delivery technology. This has been awarded under Innovate UK’s Knowledge Transfer Partnership and will fund a £250,000 collaborative research programme.
The programme of research will be undertaken by ReNeuron and the European Cancer Stem Cell Research Institute at Cardiff University and will develop novel systems to enable the delivery of therapeutic nucleic acids, such as small interfering RNA (siRNA), across the blood brain barrier using its CTX stem cell-derived exosomes.
Dr Randolph Corteling, Head of Research at ReNeuron, commented: “We and our collaborators are delighted to have won this latest grant from Innovate UK. We are very excited about the potential of our exosome technology platform to deliver therapeutic compounds to the brain and thereby to make a real step-change in the development of treatments against hard-to-target disorders of the central nervous system.”